Myriad Genetics
MYGN
#6699
Rank
S$0.85 B
Marketcap
S$9.19
Share price
-3.27%
Change (1 day)
-58.03%
Change (1 year)

Myriad Genetics (MYGN) - Total assets

Total assets on the balance sheet as of September 2025 : S$0.94 Billion

According to Myriad Genetics's latest financial reports the company's total assets are S$0.94 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Myriad Genetics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$1.39 B-7.75%
2023-12-31S$1.51 B-5.77%
2022-12-31S$1.60 B-10%
2021-12-31S$1.78 B
2020-06-30S$1.95 B-7.33%
2019-06-30S$2.11 B31.88%
2018-06-30S$1.60 B-3.75%
2017-06-30S$1.66 B40.3%
2016-06-30S$1.18 B14.9%
2015-06-30S$1.03 B0.52%
2014-06-30S$1.02 B0.68%
2013-06-30S$1.02 B16.56%
2012-06-30S$0.87 B16.74%
2011-06-30S$0.74 B-9.1%
2010-06-30S$0.82 B22.4%
2009-06-30S$0.67 B-0.86%
2008-06-30S$0.67 B17.97%
2007-06-30S$0.57 B30.85%
2006-06-30S$0.44 B63.57%
2005-06-30S$0.26 B-16.64%
2004-06-30S$0.32 B0.59%
2003-06-30S$0.32 B15.39%
2002-06-30S$0.27 B-11.34%
2001-06-30S$0.31 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Bio-Rad Laboratories
BIO
S$12.57 B 1,231.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
S$7.64 B 710.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
S$28.65 M-96.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$9.87 B 945.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$109.13 B 11,461.74%๐Ÿ‡บ๐Ÿ‡ธ USA